Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Neuroendocrine Tumors × Blood Specimen Collection × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Breast Neoplasms 52 Neoplasms 49 Colorectal Neoplasms 24 Prostatic Neoplasms 21 Lung Neoplasms 21 Neoplastic Cells, Circulating 17 Carcinoma, Non-Small-Cell Lung 17 Pancreatic Neoplasms 16 Head and Neck Neoplasms 16 Melanoma 14 Ovarian Neoplasms 11 Esophageal Neoplasms 10 Colonic Neoplasms 10 Carcinoma, Hepatocellular 10 Uterine Cervical Neoplasms 8 Liver Neoplasms 8 Glioma 8 Squamous Cell Carcinoma of Head and Neck 7 Neoplasm Metastasis 7 Multiple Myeloma 7 Leukemia, Myeloid, Acute 7 Endometrial Neoplasms 7 Neoplasm, Residual 6 Myeloproliferative Disorders 6 Kidney Neoplasms 6 Carcinoma, Renal Cell 6 Adenocarcinoma 6 Stomach Neoplasms 5 Sarcoma 5 Obesity 5

Interventions

lutetium Lu 177 dotatate 5 Data Collection 3 telotristat ethyl 2 Somatostatin 2 Positron-Emission Tomography 2 Magnetic Resonance Spectroscopy 2 Everolimus 2 Biopsy 2 lanreotide 1 copper dotatate CU-64 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Sorafenib 1 Salvage Therapy 1 Radionuclide Imaging 1 Radiomics 1 Radiofrequency Ablation 1 Plastic Surgery Procedures 1 Phlebotomy 1 Octreotide 1 Lutetium-177 1 Lutetium 1 Liver Transplantation 1 Laparoscopy 1 Drug Therapy 1 Diet, Mediterranean 1 Cytidine Triphosphate 1 Cholecystectomy 1 Blood Specimen Collection 1 Biopsy, Large-Core Needle 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06430021 2025-02-24

PRO-NEM1

Centre Hospitalier Universitaire Dijon

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡